1.The emergence of bone as an endocrine regulator through FGF23 and osteocalcin has led to the re-evaluation of the role of bone cells and bone-derived factors in the development of metabolic diseases such as T2DM.
通过FGF23和骨钙素，骨作为内分泌调节因子的出现，使人们重新评估了骨细胞和骨衍生因子在T2DM等代谢性疾病发展中的作用。